Calyx EDC Selected for RWE Data Collection in Extensive Late-Phase Trial

Calyx transforms the uncertain into the reliable through innovative eClinical and Regulatory solutions and services, assisting in the timely introduction of new medical treatments to the market

Fremont, CA: A leading pharmaceutical company had chosen Calyx's electronic data capture (EDC) system to capture Real World Evidence (RWE) data for a global, late-phase study.

The global company chose calyx EDC because of its proven effectiveness in capturing critical patient data during lengthy, international studies. In addition, calyx's ability to promptly deliver a dependable, cost-effective solution to meet the pharmaceutical company's accelerated study timelines and continuous data collection requirements was critical in its selection.

"We're thrilled to be working with this leading pharmaceutical company and to extend our 30 years of experience in delivering reliable, high-quality data to help them fully understand the long-term effects of their medical products," said Juan Munoz-Pujol, Calyx's Vice President, IRT, and EDC.